Abbott Laboratories
NYSE:ABT

  • LAST PRICE
    103.2000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    102.9800/ 6
  • Ask / Lots
    104.0400/ 1
  • Open / Previous Close
    0.0000 / 103.2000
  • Day Range
    ---
  • 52 Week Range
    89.6740
    121.6400
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ABT
Abbott Laboratories
179.5B
32.0x
+18.64%
SYK
Stryker Corp
128.2B
38.5x
+9.49%
MDT
Medtronic PLC
98.9B
27.9x
-4.17%
BDX
Becton Dickinson and Co
66.3B
48.8x
+11.04%
DXCM
Dexcom Inc
44.6B
73.9x
---
IDXX
IDEXX Laboratories Inc
39.3B
46.2x
+18.62%
As of 2024-07-02

Company Information

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

Contact Information

Headquarters
100 Abbott Park Road, Abbot ParkABBOTT PARK, IL, United States 60064-3500
Phone
224-667-6100
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Robert Ford
Chief Financial Officer, Senior Vice President - Finance
Philip Boudreau
Executive Vice President - Finance
Robert Funck
Executive Vice President, General Counsel, Secretary
Hubert Allen
Executive Vice President - Human Resources
Mary Moreland

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$179.5B
Revenue (TTM)
$40.3B
Shares Outstanding
1.7B
Dividend Yield
2.13%
Annual Dividend Rate
2.2000 USD
Ex-Dividend Date
07-15-24
Pay Date
08-15-24
Beta
0.72
EPS
$3.22
Book Value
$22.26
P/E Ratio
32.0x
Price/Sales (TTM)
4.5
Price/Cash Flow (TTM)
20.2x
Operating Margin
15.76%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.